4 results match your criteria: "Hospital General Regional No. 1 Gabriel Mancera[Affiliation]"
Arch Med Res
April 2007
Unit of Clinical Epidemiology, Hospital General Regional No. 1 Gabriel Mancera, Instituto Mexicano del Seguro Social, D. F., and Unidad de Posgrado, Universidad Autónoma del Estado de México, México.
Rev Gastroenterol Mex
February 2004
Departamento de Cirugía General del Hospital General Regional No. 1 Gabriel Mancera del Instituto Mexicano del Seguro Social, México, D.F.
The mesenteric cyst is a tumor of multiple origins, that undoubtedly presents with greater frequency than that referred in published series. Nevertheless, it continues to be a rare entity. Due to absence of characteristic signs and symptoms, diagnosis is only made once these lesions have reached a size, sufficiently large to be palpable or when they cause compression on organs or neighboring structures.
View Article and Find Full Text PDFGac Med Mex
January 2004
Departamento de Cirugía General, Hospital General Regional No. 1 Gabriel Mancera, Instituto Mexicano del Seguro Social, Cd. de México.
Mesenteric cyst is a tumor of multiple origins that surely are found more frequently than the literature report, at any rate, this tumor is uncommon. Because of absence of characteristic clinical findings, diagnosis cumbersome, until these cysts are of such a size that palpation becomes possible or when they cause compression to nearby viscera. Occasionally, diagnosis is made during surgery, even when it was emergency surgery.
View Article and Find Full Text PDFAm J Hematol
October 1998
Department of Hematology, Hospital General Regional No. 1 Gabriel Mancera, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
Infection with the human immunodeficiency virus (HIV) frequently is complicated with thrombocytopenia (HIV-Thr) during all stages of the infection. The treatments for autoimmune thrombocytopenic purpura (ITP) are used in HIV-Thr; however, their effects upon the immune status of patients with acquired immunodeficiency syndrome (AIDS) are unknown. Intravenous immunoglobulin (IVIg) is used in patients with ITP and HIV-Thr; however, its usefulness in thrombocytopenic AIDS patients has not been directly addressed.
View Article and Find Full Text PDF